text
"['\n7. 증권의 발행을 통한 자금조달에 관한 사항\n7-1. 증권의 발행을 통한 자금조달 실적\n[지분증권의 발행 등과 관련된 사항]\n가. 증자(감자)현황\n(기준일 :\xa0\n2022년 06월 30일\n)\n(단위 : 원, 주)\n주식발행(감소)일자\n발행(감소)형태\n발행(감소)한 주식의 내용\n종류\n수량\n주당액면가액\n주당발행(감소)가액\n비고\n-\n-\n-\n-\n-\n-\n-\n- 해당사항 없음.\n[채무증권의 발행 등과 관련된 사항]\n채무증권 발행실적\n(기준일 :\xa0\n2022년 06월 30일\n)\n(단위 : 백만원, %)\n발행회사\n증권종류\n발행방법\n발행일자\n권면(전자등록)총액\n이자율\n평가등급(평가기관)\n만기일\n상환여부\n주관회사\n유진투자증권\n기업어음증권\n사모\n2022.01.07\n5,000\n2.20\nA2+(NICE신용평가), A2+(한신평)\n2022.07.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.01.07\n5,000\n2.20\nA2+(NICE신용평가), A2+(한신평)\n2022.07.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.01.07\n5,000\n2.20\nA2+(NICE신용평가), A2+(한신평)\n2022.07.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.01.07\n5,000\n2.20\nA2+(NICE신용평가), A2+(한신평)\n2022.07.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.01.26\n5,000\n2.43\nA2+(NICE신용평가), A2+(한신평)\n2022.07.26\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.01.26\n5,000\n2.43\nA2+(NICE신용평가), A2+(한신평)\n2022.07.26\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.01.26\n5,000\n2.43\nA2+(NICE신용평가), A2+(한신평)\n2022.07.26\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.01.26\n5,000\n2.43\nA2+(NICE신용평가), A2+(한신평)\n2022.07.26\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.01.26\n5,000\n2.43\nA2+(NICE신용평가), A2+(한신평)\n2022.07.26\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.01.26\n5,000\n2.43\nA2+(NICE신용평가), A2+(한신평)\n2022.07.26\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.01.26\n5,000\n2.43\nA2+(NICE신용평가), A2+(한신평)\n2022.07.26\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.01.26\n5,000\n2.43\nA2+(NICE신용평가), A2+(한신평)\n2022.07.26\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.01.26\n5,000\n2.43\nA2+(NICE신용평가), A2+(한신평)\n2022.07.26\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.01.26\n5,000\n2.43\nA2+(NICE신용평가), A2+(한신평)\n2022.07.26\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.04\n5,000\n2.27\nA2+(NICE신용평가), A2+(한신평)\n2022.08.04\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.04\n5,000\n2.27\nA2+(NICE신용평가), A2+(한신평)\n2022.08.04\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.04\n5,000\n2.27\nA2+(NICE신용평가), A2+(한신평)\n2022.08.04\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.04\n5,000\n2.27\nA2+(NICE신용평가), A2+(한신평)\n2022.08.04\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.04\n5,000\n2.27\nA2+(NICE신용평가), A2+(한신평)\n2022.08.04\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.04\n5,000\n2.27\nA2+(NICE신용평가), A2+(한신평)\n2022.08.04\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.04\n5,000\n2.27\nA2+(NICE신용평가), A2+(한신평)\n2022.08.04\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.04\n5,000\n2.27\nA2+(NICE신용평가), A2+(한신평)\n2022.08.04\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.04\n5,000\n2.27\nA2+(NICE신용평가), A2+(한신평)\n2022.08.04\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.04\n5,000\n2.27\nA2+(NICE신용평가), A2+(한신평)\n2022.08.04\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.17\n5,000\n2.48\nA2+(NICE신용평가), A2+(한신평)\n2023.02.16\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.17\n5,000\n2.48\nA2+(NICE신용평가), A2+(한신평)\n2023.02.16\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.17\n5,000\n2.48\nA2+(NICE신용평가), A2+(한신평)\n2023.02.16\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.17\n5,000\n2.48\nA2+(NICE신용평가), A2+(한신평)\n2023.02.16\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.17\n5,000\n2.48\nA2+(NICE신용평가), A2+(한신평)\n2023.02.16\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.17\n5,000\n2.48\nA2+(NICE신용평가), A2+(한신평)\n2023.02.16\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.17\n5,000\n2.48\nA2+(NICE신용평가), A2+(한신평)\n2023.02.16\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.17\n5,000\n2.48\nA2+(NICE신용평가), A2+(한신평)\n2023.02.16\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.17\n5,000\n2.48\nA2+(NICE신용평가), A2+(한신평)\n2023.02.16\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.02.17\n5,000\n2.48\nA2+(NICE신용평가), A2+(한신평)\n2023.02.16\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.03\n10,000\n2.10\nA2+(NICE신용평가), A2+(한신평)\n2022.06.03\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.03\n10,000\n2.10\nA2+(NICE신용평가), A2+(한신평)\n2022.06.03\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.03\n5,000\n2.22\nA2+(NICE신용평가), A2+(한신평)\n2022.09.05\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.03\n5,000\n2.22\nA2+(NICE신용평가), A2+(한신평)\n2022.09.05\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.04\n5,000\n2.22\nA2+(NICE신용평가), A2+(한신평)\n2022.09.02\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.04\n3,000\n2.22\nA2+(NICE신용평가), A2+(한신평)\n2022.09.02\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.04\n3,000\n2.22\nA2+(NICE신용평가), A2+(한신평)\n2022.09.02\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.10\n5,000\n2.22\nA2+(NICE신용평가), A2+(한신평)\n2022.09.13\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.10\n5,000\n2.22\nA2+(NICE신용평가), A2+(한신평)\n2022.09.13\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.10\n5,000\n2.13\nA2+(NICE신용평가), A2+(한신평)\n2022.06.10\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.10\n5,000\n2.13\nA2+(NICE신용평가), A2+(한신평)\n2022.06.10\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.10\n5,000\n2.13\nA2+(NICE신용평가), A2+(한신평)\n2022.06.10\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.10\n5,000\n2.13\nA2+(NICE신용평가), A2+(한신평)\n2022.06.10\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.15\n10,000\n2.28\nA2+(NICE신용평가), A2+(한신평)\n2022.10.14\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.16\n10,000\n2.28\nA2+(NICE신용평가), A2+(한신평)\n2022.10.14\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.29\n5,000\n2.65\nA2+(NICE신용평가), A2+(한신평)\n2023.03.28\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.29\n5,000\n2.65\nA2+(NICE신용평가), A2+(한신평)\n2023.03.28\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.29\n5,000\n2.65\nA2+(NICE신용평가), A2+(한신평)\n2023.03.28\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.03.29\n5,000\n2.65\nA2+(NICE신용평가), A2+(한신평)\n2023.03.28\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.04.07\n10,000\n2.32\nA2+(NICE신용평가), A2+(한신평)\n2022.10.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.04.07\n10,000\n2.32\nA2+(NICE신용평가), A2+(한신평)\n2022.10.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.04.07\n10,000\n2.32\nA2+(NICE신용평가), A2+(한신평)\n2022.10.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.04.07\n10,000\n2.32\nA2+(NICE신용평가), A2+(한신평)\n2022.10.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.04.07\n10,000\n2.32\nA2+(NICE신용평가), A2+(한신평)\n2022.10.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.04.18\n5,000\n2.60\nA2+(NICE신용평가), A2+(한신평)\n2023.02.17\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.05.09\n4,000\n2.52\nA2+(NICE신용평가), A2+(한신평)\n2022.12.09\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.05.09\n1,000\n2.52\nA2+(NICE신용평가), A2+(한신평)\n2022.12.09\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.05.10\n5,000\n2.43\nA2+(NICE신용평가), A2+(한신평)\n2022.09.15\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.05.10\n5,000\n2.43\nA2+(NICE신용평가), A2+(한신평)\n2022.09.15\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.05.10\n5,000\n2.43\nA2+(NICE신용평가), A2+(한신평)\n2022.09.15\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.05.18\n5,000\n2.51\nA2+(NICE신용평가), A2+(한신평)\n2022.09.20\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.05.18\n5,000\n2.51\nA2+(NICE신용평가), A2+(한신평)\n2022.09.20\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.05.18\n5,000\n2.51\nA2+(NICE신용평가), A2+(한신평)\n2022.09.20\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.05.18\n5,000\n2.51\nA2+(NICE신용평가), A2+(한신평)\n2022.09.20\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.05.19\n5,000\n2.51\nA2+(NICE신용평가), A2+(한신평)\n2022.09.20\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.05.19\n5,000\n2.51\nA2+(NICE신용평가), A2+(한신평)\n2022.09.20\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.05.20\n10,000\n2.66\nA2+(NICE신용평가), A2+(한신평)\n2022.10.12\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.06.03\n10,000\n2.85\nA2+(NICE신용평가), A2+(한신평)\n2022.09.02\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.06.03\n10,000\n2.85\nA2+(NICE신용평가), A2+(한신평)\n2022.09.02\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.06.09\n5,000\n3.02\nA2+(NICE신용평가), A2+(한신평)\n2022.10.31\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.06.09\n5,000\n3.02\nA2+(NICE신용평가), A2+(한신평)\n2022.10.31\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.06.09\n5,000\n3.02\nA2+(NICE신용평가), A2+(한신평)\n2022.10.31\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.06.09\n5,000\n3.02\nA2+(NICE신용평가), A2+(한신평)\n2022.10.31\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.06.09\n5,000\n3.02\nA2+(NICE신용평가), A2+(한신평)\n2022.10.31\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.06.09\n5,000\n3.02\nA2+(NICE신용평가), A2+(한신평)\n2022.10.31\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.06.09\n5,000\n3.02\nA2+(NICE신용평가), A2+(한신평)\n2022.10.31\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.06.09\n5,000\n3.02\nA2+(NICE신용평가), A2+(한신평)\n2022.10.31\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.06.09\n5,000\n3.02\nA2+(NICE신용평가), A2+(한신평)\n2022.10.31\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.06.09\n5,000\n3.02\nA2+(NICE신용평가), A2+(한신평)\n2022.10.31\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.06.09\n10,000\n3.02\nA2+(NICE신용평가), A2+(한신평)\n2022.10.31\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.06.09\n10,000\n3.02\nA2+(NICE신용평가), A2+(한신평)\n2022.10.31\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2022.06.14\n5,000\n3.62\nA2+(NICE신용평가), A2+(한신평)\n2023.02.14\n미상환\n-\n유진투자증권\n전자단기사채\n사모\n2022.01.05\n30,000\n2.10\nA2+(NICE신용평가), A2+(한신평)\n2022.04.05\n상환\n-\n유진투자증권\n전자단기사채\n사모\n2022.02.03\n50,000\n2.22\nA2+(NICE신용평가), A2+(한신평)\n2022.05.03\n상환\n-\n유진투자증권\n전자단기사채\n사모\n2022.02.11\n10,000\n2.16\nA2+(NICE신용평가), A2+(한신평)\n2022.05.11\n상환\n-\n유진투자증권\n전자단기사채\n사모\n2022.02.11\n30,000\n2.14\nA2+(NICE신용평가), A2+(한신평)\n2022.05.10\n상환\n-\n유진투자증권\n전자단기사채\n사모\n2022.02.25\n20,000\n2.12\nA2+(NICE신용평가), A2+(한신평)\n2022.05.25\n상환\n-\n유진투자증권\n전자단기사채\n사모\n2022.03.02\n20,000\n2.12\nA2+(NICE신용평가), A2+(한신평)\n2022.06.02\n상환\n-\n유진투자증권\n전자단기사채\n사모\n2022.04.01\n20,000\n2.21\nA2+(NICE신용평가), A2+(한신평)\n2022.07.01\n미상환\n-\n유진투자증권\n전자단기사채\n사모\n2022.04.01\n10,000\n2.21\nA2+(NICE신용평가), A2+(한신평)\n2022.07.01\n미상환\n-\n유진투자증권\n전자단기사채\n사모\n2022.05.03\n10,000\n2.32\nA2+(NICE신용평가), A2+(한신평)\n2022.08.03\n미상환\n-\n유진투자증권\n전자단기사채\n사모\n2022.05.09\n5,000\n2.42\nA2+(NICE신용평가), A2+(한신평)\n2022.08.09\n미상환\n-\n유진투자증권\n전자단기사채\n사모\n2022.05.10\n30,000\n2.42\nA2+(NICE신용평가), A2+(한신평)\n2022.08.10\n미상환\n-\n유진투자증권\n전자단기사채\n사모\n2022.05.10\n20,000\n2.39\nA2+(NICE신용평가), A2+(한신평)\n2022.07.11\n미상환\n-\n유진투자증권\n전자단기사채\n사모\n2022.05.11\n10,000\n2.42\nA2+(NICE신용평가), A2+(한신평)\n2022.08.11\n미상환\n-\n유진투자증권\n전자단기사채\n사모\n2022.05.30\n30,000\n2.88\nA2+(NICE신용평가), A2+(한신평)\n2022.08.29\n미상환\n-\n해피니스레드㈜\n전자단기사채\n사모\n2022.01.24\n10,000\n2.55\nA2+(NICE신용평가), A2+(한신평)\n2022.03.24\n상환\n유진투자증권\n해피니스레드㈜\n전자단기사채\n사모\n2022.03.24\n10,000\n2.40\nA2+(NICE신용평가), A2+(한신평)\n2022.05.24\n상환\n유진투자증권\n해피니스레드㈜\n전자단기사채\n사모\n2022.05.24\n10,000\n2.70\nA2+(NICE신용평가), A2+(한신평)\n2022.07.22\n미상환\n유진투자증권\n챔피언별내제일차㈜\n전자단기사채\n사모\n2022.02.25\n15,000\n2.50\nA2+(한신평), A2+(한기평)\n2022.04.25\n상환\n유진투자증권\n챔피언별내제일차㈜\n전자단기사채\n사모\n2022.04.25\n15,000\n2.40\nA2+(한신평), A2+(한기평)\n2022.05.26\n상환\n유진투자증권\n챔피언별내제일차㈜\n전자단기사채\n사모\n2022.05.26\n15,000\n2.80\nA2+(한신평), A2+(한기평)\n2022.08.26\n미상환\n유진투자증권\n챔피언우암제이차㈜\n전자단기사채\n사모\n2022.02.07\n15,000\n2.60\nA2+(NICE신용평가), A2+(한신평)\n2022.05.07\n상환\n유진투자증권\n챔피언우암제이차㈜\n전자단기사채\n사모\n2022.05.09\n15,000\n2.57\nA2+(NICE신용평가), A2+(한신평)\n2022.08.08\n미상환\n유진투자증권\n챔피언레스큐㈜\n전자단기사채\n사모\n2022.06.17\n20,500\n3.70\nA2+(NICE신용평가), A2+(한신평)\n2022.07.18\n미상환\n유진투자증권\n챔피언레스큐㈜\n전자단기사채\n사모\n2022.06.17\n3,000\n3.55\nA2+(NICE신용평가), A2+(한신평)\n2022.09.17\n미상환\n유진투자증권\n파크스퀘어제이차㈜\n전자단기사채\n사모\n2022.01.27\n14,500\n2.50\nA2+(NICE신용평가), A2+(한신평)\n2022.03.25\n상환\n유진투자증권\n파크스퀘어제이차㈜\n전자단기사채\n사모\n2022.03.25\n14,500\n2.45\nA2+(NICE신용평가), A2+(한신평)\n2022.05.02\n상환\n유진투자증권\n파크스퀘어제이차㈜\n전자단기사채\n사모\n2022.05.02\n14,500\n2.55\nA2+(NICE신용평가), A2+(한신평)\n2022.06.02\n상환\n유진투자증권\n파크스퀘어제이차㈜\n전자단기사채\n사모\n2022.06.02\n14,500\n2.90\nA2+(NICE신용평가), A2+(한신평)\n2022.07.01\n미상환\n유진투자증권\n에프엠유동화제일차㈜\n전자단기사채\n사모\n2022.03.03\n30,000\n2.55\nA2+(NICE신용평가), A2+(한신평)\n2022.06.03\n상환\n유진투자증권\n에프엠유동화제일차㈜\n전자단기사채\n사모\n2022.06.03\n30,000\n3.15\nA2+(NICE신용평가), A2+(한신평)\n2022.09.02\n미상환\n유진투자증권\n유진에스에프제일차㈜\xa0\n전자단기사채\n사모\n2022.06.10\n19,200\n3.10\nA2+(한신평), A2+(한기평)\n2022.09.10\n미상환\n유진투자증권\xa0\n씨에스지제일차㈜\n전자단기사채\n사모\n2022.03.06\n13,900\n2.48\nA2+(NICE신용평가), A2+(한기평)\n2022.06.06\n상환\n유진투자증권\n씨에스지제일차㈜\n전자단기사채\n사모\n2022.06.07\n13,900\n2.90\nA2+(NICE신용평가), A2+(한기평)\n2022.09.06\n미상환\n유진투자증권\n합 \xa0계\n-\n-\n-\n1,079,500\n-\n-\n-\n-\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0기업어음증권 미상환 잔액 (연결 기준)\n(기준일 :\xa0\n2022년 06월 30일\n)\n(단위 : 백만원)\n잔여만기\n10일 이하\n10일초과30일이하\n30일초과90일이하\n90일초과180일이하\n180일초과1년이하\n1년초과2년이하\n2년초과3년이하\n3년 초과\n합 계\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n20,000\n60,000\n216,000\n245,000\n80,000\n-\n-\n-\n621,000\n합계\n20,000\n60,000\n216,000\n245,000\n80,000\n-\n-\n-\n621,000\n기업어음증권 미상환 잔액 (별도 기준)\n(기준일 :\xa0\n2022년 06월 30일\n)\n(단위 : 백만원)\n잔여만기\n10일 이하\n10일초과30일이하\n30일초과90일이하\n90일초과180일이하\n180일초과1년이하\n1년초과2년이하\n2년초과3년이하\n3년 초과\n합 계\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n20,000\xa0\n60,000\xa0\n216,000\xa0\n245,000\xa0\n80,000\xa0\n-\n-\n-\n621,000\xa0\n합계\n20,000\xa0\n60,000\xa0\n216,000\xa0\n245,000\xa0\n80,000\xa0\n-\n-\n-\n621,000\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 단기사채 미상환 잔액 (연결 기준)\n(기준일 :\xa0\n2022년 06월 30일\n)\n(단위 : 백만원)\n잔여만기\n10일 이하\n10일초과30일이하\n30일초과90일이하\n90일초과180일이하\n180일초과1년이하\n합 계\n발행 한도\n잔여 한도\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n44,500\n50,500\n181,100\n-\n-\n276,100\n-\n-\n합계\n44,500\n50,500\n181,100\n-\n-\n276,100\n591,100\n315,000\n단기사채 미상환 잔액 (별도 기준)\n(기준일 :\xa0\n2022년 06월 30일\n)\n(단위 : 백만원)\n잔여만기\n10일 이하\n10일초과30일이하\n30일초과90일이하\n90일초과180일이하\n180일초과1년이하\n합 계\n발행 한도\n잔여 한도\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n30,000\n20,000\n85,000\n-\n-\n135,000\n-\n-\n합계\n30,000\n20,000\n85,000\n-\n-\n135,000\n450,000\n315,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0회사채 미상환 잔액 (연결 기준)\n(기준일 :\xa0\n2022년 06월 30일\n)\n(단위 : 백만원)\n잔여만기\n1년 이하\n1년초과2년이하\n2년초과3년이하\n3년초과4년이하\n4년초과5년이하\n5년초과10년이하\n10년초과\n합 계\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n10,000\n-\n-\n-\n40,000\n-\n-\n50,000\n합계\n10,000\n-\n-\n-\n40,000\n-\n-\n50,000\n회사채 미상환 잔액 (별도 기준)\n(기준일 :\xa0\n2022년 06월 30일\n)\n(단위 : 백만원)\n잔여만기\n1년 이하\n1년초과2년이하\n2년초과3년이하\n3년초과4년이하\n4년초과5년이하\n5년초과10년이하\n10년초과\n합 계\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n10,000\n-\n-\n-\n40,000\n-\n-\n50,000\n합계\n10,000\n-\n-\n-\n40,000\n-\n-\n50,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0신종자본증권 미상환 잔액 (연결 기준)\n(기준일 :\xa0\n2022년 06월 30일\n)\n(단위 : 백만원)\n잔여만기\n1년 이하\n1년초과5년이하\n5년초과10년이하\n10년초과15년이하\n15년초과20년이하\n20년초과30년이하\n30년초과\n합 계\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n-\n-\n-\n-\n-\n-\n-\n-\n합계\n-\n-\n-\n-\n-\n-\n-\n-\n\xa0 \xa0 신종자본증권 미상환 잔액 (별도 기준)\n(기준일 :\xa0\n2022년 06월 30일\n)\n(단위 : 백만원)\n잔여만기\n1년 이하\n1년초과5년이하\n5년초과10년이하\n10년초과15년이하\n15년초과20년이하\n20년초과30년이하\n30년초과\n합 계\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n-\n-\n-\n-\n-\n-\n-\n-\n합계\n-\n-\n-\n-\n-\n-\n-\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0조건부자본증권 미상환 잔액 (연결 기준)\n(기준일 :\xa0\n2022년 06월 30일\n)\n(단위 : 백만원)\n잔여만기\n1년 이하\n1년초과2년이하\n2년초과3년이하\n3년초과4년이하\n4년초과5년이하\n5년초과10년이하\n10년초과20년이하\n20년초과30년이하\n30년초과\n합 계\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n-\n-\n-\n-\n-\n-\n-\n-\n-\n-\n합계\n-\n-\n-\n-\n-\n-\n-\n-\n-\n-\n\xa0 \xa0 \xa0 \xa0 조건부자본증권 미상환 잔액 (별도 기준)\n(기준일 :\xa0\n2022년 06월 30일\n)\n(단위 : 백만원)\n잔여만기\n1년 이하\n1년초과2년이하\n2년초과3년이하\n3년초과4년이하\n4년초과5년이하\n5년초과10년이하\n10년초과20년이하\n20년초과30년이하\n30년초과\n합 계\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n-\n-\n-\n-\n-\n-\n-\n-\n-\n-\n합계\n-\n-\n-\n-\n-\n-\n-\n-\n-\n-\n7-2. 증권의 발행을 통해 조달된 자금의 사용실적\n가. 사모자금의 사용내역\n(기준일 :\xa0\n2022년 06월 30일\n)\n(단위 : 백만원)\n구 분\n회차\n납입일\n주요사항보고서의 자금사용 계획\n실제 자금사용 내역\n차이발생 사유 등\n사용용도\n조달금액\n내용\n금액\n후순위사채\n15\n2020년 03월 19일\n운영자금\n40,000\n운영자금\n40,000\n-\n']"
